S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
A.I. ETF Sold Out Of Monster Energy, Three Ways To Look At It
Graphite versus Lithium - What Investors Should Know (Ad)
Stock market today: Wall Street futures point higher on debt deal, but some tremors in retail
Alibaba Unveils Its Spin-Off Plans
Graphite versus Lithium - What Investors Should Know (Ad)
The Most Upgraded Stocks From The Q1 Earnings Season
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
The $193 Billion US-China War You Don't Know About (Ad)
Can These Two Crypto Stocks Stage a Comeback?
Advance Auto Parts Backfires: Is This A Warning For The S&P 500?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
A.I. ETF Sold Out Of Monster Energy, Three Ways To Look At It
Graphite versus Lithium - What Investors Should Know (Ad)
Stock market today: Wall Street futures point higher on debt deal, but some tremors in retail
Alibaba Unveils Its Spin-Off Plans
Graphite versus Lithium - What Investors Should Know (Ad)
The Most Upgraded Stocks From The Q1 Earnings Season
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
The $193 Billion US-China War You Don't Know About (Ad)
Can These Two Crypto Stocks Stage a Comeback?
Advance Auto Parts Backfires: Is This A Warning For The S&P 500?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
A.I. ETF Sold Out Of Monster Energy, Three Ways To Look At It
Graphite versus Lithium - What Investors Should Know (Ad)
Stock market today: Wall Street futures point higher on debt deal, but some tremors in retail
Alibaba Unveils Its Spin-Off Plans
Graphite versus Lithium - What Investors Should Know (Ad)
The Most Upgraded Stocks From The Q1 Earnings Season
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
The $193 Billion US-China War You Don't Know About (Ad)
Can These Two Crypto Stocks Stage a Comeback?
Advance Auto Parts Backfires: Is This A Warning For The S&P 500?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
A.I. ETF Sold Out Of Monster Energy, Three Ways To Look At It
Graphite versus Lithium - What Investors Should Know (Ad)
Stock market today: Wall Street futures point higher on debt deal, but some tremors in retail
Alibaba Unveils Its Spin-Off Plans
Graphite versus Lithium - What Investors Should Know (Ad)
The Most Upgraded Stocks From The Q1 Earnings Season
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
The $193 Billion US-China War You Don't Know About (Ad)
Can These Two Crypto Stocks Stage a Comeback?
Advance Auto Parts Backfires: Is This A Warning For The S&P 500?
NASDAQ:ATEC

Alphatec (ATEC) Stock Forecast, Price & News

$15.16
+0.32 (+2.16%)
(As of 05/31/2023 ET)
Compare
Today's Range
$14.78
$15.34
50-Day Range
$14.32
$16.38
52-Week Range
$5.73
$17.13
Volume
939,085 shs
Average Volume
1.12 million shs
Market Capitalization
$1.80 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.25

Alphatec MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.83 Rating Score
Upside/​Downside
7.2% Upside
$16.25 Price Target
Short Interest
Bearish
10.76% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.67
Upright™ Environmental Score
News Sentiment
0.98mentions of Alphatec in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$990.67 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.21) to ($0.88) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.78 out of 5 stars

Medical Sector

822nd out of 1,006 stocks

Surgical & Medical Instruments Industry

84th out of 104 stocks


ATEC stock logo

About Alphatec (NASDAQ:ATEC) Stock

Alphatec Holdings, Inc. engages in the design, development, and marketing of spinal fusion technology products and solutions for the treatment of spinal disorders. It offers intra-operative information and neuromonitoring technologies, access systems, interbody implants, fixation systems, and various biologics offerings. The company was founded on March 4, 2005 and is headquartered in Carlsbad, CA.

Receive ATEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alphatec and its competitors with MarketBeat's FREE daily newsletter.

ATEC Stock News Headlines

Where Alphatec Holdings Stands With Analysts
The $193 Billion US-China War You Don't Know About
They're fighting for control of lithium – a key ingredient in EVs and clean energy technology. It's arguably the most important commodity of the 21st century. China owns 80% of global supply. But the US plans to grab a massive slice of the lithium market, which is forecasted to quadruple to $193 billion by 2028, according to Fortune Business Insights.
The $193 Billion US-China War You Don't Know About
They're fighting for control of lithium – a key ingredient in EVs and clean energy technology. It's arguably the most important commodity of the 21st century. China owns 80% of global supply. But the US plans to grab a massive slice of the lithium market, which is forecasted to quadruple to $193 billion by 2028, according to Fortune Business Insights.
StockNews.com Lowers Alphatec (NASDAQ:ATEC) to Sell
Alphatec: A Balancing Act
ATEC Reports First Quarter 2023 Financial Results
Alphatec (ATEC) Set to Announce Earnings on Thursday
Alphatec (NASDAQ:ATEC) Sees Strong Trading Volume
Alphatec Holdings (ATEC) Receives a Buy from Needham
Aircraft VHF Radios Market Forecast to 2031
See More Headlines
Receive ATEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alphatec and its competitors with MarketBeat's FREE daily newsletter.

ATEC Company Calendar

Last Earnings
11/04/2021
Today
5/31/2023
Next Earnings (Estimated)
8/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:ATEC
CUSIP
02081G10
Employees
561
Year Founded
1990

Price Target and Rating

Average Stock Price Forecast
$16.25
High Stock Price Forecast
$20.00
Low Stock Price Forecast
$9.50
Forecasted Upside/Downside
+7.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.83
Research Coverage
6 Analysts

Profitability

Net Income
$-152,150,000.00
Pretax Margin
-39.28%

Debt

Sales & Book Value

Annual Sales
$350.87 million
Book Value
($0.49) per share

Miscellaneous

Free Float
78,291,000
Market Cap
$1.80 billion
Optionable
Not Optionable
Beta
1.25

Social Links


Key Executives

  • Patrick S. MilesPatrick S. Miles
    Chairman, President, CEO & COO
  • J. Todd Koning
    Chief Financial Officer & Executive Vice President
  • Scott LishScott Lish
    Senior Vice President-Research & Development
  • Kelli M. Howell
    Executive Vice President-Clinical Strategies
  • Luiz Pimenta
    Chief Medical Officer













ATEC Stock - Frequently Asked Questions

Should I buy or sell Alphatec stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alphatec in the last twelve months. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ATEC shares.
View ATEC analyst ratings
or view top-rated stocks.

What is Alphatec's stock price forecast for 2023?

6 brokers have issued 12-month price objectives for Alphatec's stock. Their ATEC share price forecasts range from $9.50 to $20.00. On average, they expect the company's share price to reach $16.25 in the next year. This suggests a possible upside of 7.2% from the stock's current price.
View analysts price targets for ATEC
or view top-rated stocks among Wall Street analysts.

How have ATEC shares performed in 2023?

Alphatec's stock was trading at $12.35 at the start of the year. Since then, ATEC shares have increased by 22.8% and is now trading at $15.16.
View the best growth stocks for 2023 here
.

When is Alphatec's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our ATEC earnings forecast
.

How were Alphatec's earnings last quarter?

Alphatec Holdings, Inc. (NASDAQ:ATEC) announced its quarterly earnings results on Thursday, November, 4th. The medical technology company reported ($0.43) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.23) by $0.20. The medical technology company had revenue of $62.88 million for the quarter, compared to analysts' expectations of $61.43 million. Alphatec had a negative trailing twelve-month return on equity of 575.45% and a negative net margin of 39.28%. During the same period in the prior year, the business earned ($0.18) EPS.

What guidance has Alphatec issued on next quarter's earnings?

Alphatec issued an update on its first quarter 2023 earnings guidance on Wednesday, April, 19th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $108.00 million-$109.50 million, compared to the consensus revenue estimate of $101.59 million.

What is Pat Miles' approval rating as Alphatec's CEO?

19 employees have rated Alphatec Chief Executive Officer Pat Miles on Glassdoor.com. Pat Miles has an approval rating of 72% among the company's employees. 63.0% of employees surveyed would recommend working at Alphatec to a friend.

What other stocks do shareholders of Alphatec own?
What is Alphatec's stock symbol?

Alphatec trades on the NASDAQ under the ticker symbol "ATEC."

Who are Alphatec's major shareholders?

Alphatec's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include First Light Asset Management LLC (2.48%), Next Century Growth Investors LLC (1.78%), State Street Corp (1.62%), Cerity Partners LLC (1.57%), JPMorgan Chase & Co. (1.53%) and Geode Capital Management LLC (1.23%). Insiders that own company stock include Craig E Hunsaker, David H Mowry, David R Pelizzon, David Sponsel, Elizabeth Ann Altman, Evan Bakst, James L L Tullis, James L L Tullis, Jason Hochberg, Jeffrey G Black, Jennifer N Pritzker, Jennifer N Pritzker, John Todd Koning, L-5 Healthcare Partners, Llc, Mortimer Berkowitz III, Patrick Miles, Paul Segal and Scott Lish.
View institutional ownership trends
.

How do I buy shares of Alphatec?

Shares of ATEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Alphatec's stock price today?

One share of ATEC stock can currently be purchased for approximately $15.16.

How much money does Alphatec make?

Alphatec (NASDAQ:ATEC) has a market capitalization of $1.80 billion and generates $350.87 million in revenue each year. The medical technology company earns $-152,150,000.00 in net income (profit) each year or ($1.44) on an earnings per share basis.

How many employees does Alphatec have?

The company employs 561 workers across the globe.

How can I contact Alphatec?

Alphatec's mailing address is 5818 EL CAMINO REAL, CARLSBAD CA, 92008. The official website for the company is www.atecspine.com. The medical technology company can be reached via phone at (760) 431-9286, via email at ir@alphatecspine.com, or via fax at 800-922-1356.

This page (NASDAQ:ATEC) was last updated on 6/1/2023 by MarketBeat.com Staff

My Account -